Demo Sign up Log In

Antares Pharma, Inc. (ATRS)

Deferred Revenue

$3.10M

Quarterly · Period ending: Mar 31, 2022 · USD

ATRS Deferred Revenue

Latest reported$4.43Mperiod endingDec 31, 2021

Latest reported$4.43Mperiod endingDec 31, 2021

ATRS FY Deferred Revenue ($0.00 → $4.43M)

Annual deferred revenue

High-resolution chart · PNG

ATRS deferred revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Deferred Revenue — Annual fiscal periods (USD)
Period ending	Deferred Revenue (USD)
Dec 31, 2021	4,427,000
Dec 31, 2020	3,943,000
Dec 31, 2019	1,738,000
Dec 31, 2018	1,018,000
Dec 31, 2017	2,794,000
Dec 31, 2016	6,149,087
Dec 31, 2015	5,143,825
Dec 31, 2014	8,520,517
Dec 31, 2013	4,531,220
Dec 31, 2012	2,157,016
Dec 31, 2011	5,644,278
Dec 31, 2010	3,080,062
Dec 31, 2009	5,311,516
Dec 31, 2008	1,179,820
Dec 31, 2007	964,673
Dec 31, 2006	1,014,337
Dec 31, 2005	604,143
Dec 31, 2004	547,006
Dec 31, 2003	809,945
Dec 31, 2002	1,859,288
Dec 31, 2001	1,511,198
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.